BOD Australia Ltd
ASX:BOD

Watchlist Manager
BOD Australia Ltd Logo
BOD Australia Ltd
ASX:BOD
Watchlist
Price: 0.024 AUD Market Closed
Market Cap: AU$4.3m

Net Margin

12%
Current
Improving
by 179.8%
vs 3-y average of -167.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
12%
=
Net Income
AU$259k
/
Revenue
AU$2.2m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
12%
=
Net Income
AU$259k
/
Revenue
AU$2.2m

Peer Comparison

Country Company Market Cap Net
Margin
AU
BOD Australia Ltd
ASX:BOD
4.3m AUD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
530.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
212.8B GBP
Loading...
CH
Novartis AG
SIX:NOVN
222.3B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
267.6B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.1B USD
Loading...
FR
Sanofi SA
PAR:SAN
97.2B EUR
Loading...

Market Distribution

Higher than 83% of companies in Australia
Percentile
83rd
Based on 4 004 companies
83rd percentile
12%
Low
-16 177 900% — -544.7%
Typical Range
-544.7% — 3.1%
High
3.1% — 3 174 540%
Distribution Statistics
Australia
Min -16 177 900%
30th Percentile -544.7%
Median -27.7%
70th Percentile 3.1%
Max 3 174 540%

BOD Australia Ltd
Glance View

Market Cap
4.3m AUD
Industry
Pharmaceuticals

Bod Australia Ltd. operates as a developer, manufacturer, distributor, importer, exporter and marketer of skincare, beauty, and health industries for the natural segment of the market. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-10-27. The firm is engaged in the development and manufacture of cannabidiol (CBD) and hemp products for consumer markets in Australia and United Kingdom, as well as the development, manufacture and distribution of therapeutics medicinal cannabis products. The firm operates through three segments: medical, over the counter cannabidiol/Hemp (OTC CBD/Hemp) and OTC Herbals.

BOD Intrinsic Value
0.039 AUD
Undervaluation 38%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
12%
=
Net Income
AU$259k
/
Revenue
AU$2.2m
What is BOD Australia Ltd's current Net Margin?

The current Net Margin for BOD Australia Ltd is 12%, which is above its 3-year median of -167.8%.

How has Net Margin changed over time?

Over the last 3 years, BOD Australia Ltd’s Net Margin has increased from -106.3% to 12%. During this period, it reached a low of -379.3% on Dec 31, 2023 and a high of 12% on Jul 30, 2025.

Back to Top